


Today, among the companies catching investors' attention with important stock developments and agreements are Novo Nordisk (NVO), ServiceNow (NOW), TrueCar (TRUE), KCHOL, YEOTK, and AGROT.
Following the approval of Novo Nordisk’s GLP-1 weight loss pill by the U.S. Food and Drug Administration, the company's shares gained interest among investors. This approval is seen as a significant step in the healthcare sector and could positively impact Novo Nordisk's market value.
ServiceNow announced that it will acquire the cybersecurity company Armis for $7.75 billion in cash. This strategic move will expand ServiceNow’s product range and increase the company’s influence in the cybersecurity sector.
TrueCar shareholders approved the agreement for the company to be acquired by Fair Holdings and delisted from the stock exchange. This development is considered an important step that will change TrueCar’s position in the market.
In a statement by Gen İlaç (GENIL), it was noted that the tender associated with Salutem Ecza Deposu remained in its favor. This situation will contribute 227.03 million TL to Gen İlaç's sales.
SDT Uzay ve Savunma (SDTTR) received a total defense systems order worth $1.33 million from a domestic customer. Additionally, Bülbüloğlu Vinç (BVSAN) signed a contract for crane production and delivery worth 408,000 euros with a domestic company.
Please note that the information provided here does not constitute investment advice. It is important to conduct thorough research before making investment decisions.
```.png)
Sizlere kesintisiz haber ve analizi en hızlı şekilde ulaştırmak için. Yakında tüm platformlarda...